Qiming News

Qiming Venture Partners to Hold 12th CEO Summit on 18-20th November

11/11/2020 | Qiming Venture Partners

Qiming Venture Partners today announces that the 12th Qiming Venture Partners CEO Summit will be held on 18th-20th November 2020 (China Time).

Since its debut in 2009, Qiming’s CEO Summit has been a flagship event aiming to facilitate communications among our portfolio CEOs, industry veterans, professional experts, and other thought leaders. Due to COVID-19, the 2020 Summit will take place online for the first time in history, and this enables us to make this event entirely public and accommodate more speakers in the event.

The three half-day event will be scheduled as follows: Day 1: CEO Webinar (18th November), Day 2: TMT Track (19th November) and Day 3: Healthcare Track (20th November).

In CEO Webinar session, experts from top investment banks, law firms and other institutions will coach on issues including ESOP, company legal structure and IPO strategies. In the TMT and Healthcare session, around 15 CEOs from each sector will share insights and experiences - many for the first time - at the summit.

Highlighted speakers include Mr. Zhongru Gan, Founder and Chairman of Gan & Lee Pharmaceuticals, Mr. Xuefeng Yu, Chairman and CEO of CanSino Biologics Inc., Mr. Wen Zhang, Founder and Chairman of Biren Technology and Mr. Feng Chu, Founder and CEO of WorkTrans, among others.

The conversations will cover the latest trends of technology innovation, opportunities and challenges facing the industries, as well as the future directions in subsectors, including SaaS, semiconductors, consumption and healthcare.

For the past ten months, COVID-19 has transformed the world in various ways. In such a time, perseverance is crucial to enterprises. This inspired us to decide on the theme of "Advance with Tenacity" for the Summit.

Qiming welcomes the audience from the globe to join our 2020 virtual summit on 18th-20th November 2020. The conference can be accessed via desktop and mobile devices. Simultaneous interpretation will be available.